Stay updated with breaking news from Volker Herrmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced the unveiling of a new company – Sonata Therapeutics – to develop...
Sonata Therapeutics is developing drugs that reprogram cellular microenvironments to send signals intended to have curative effects. Cancer is the initial focus of the biotech, which Flagship Pioneering formed by combining two of its preclinical portfolio companies.
Platform insights are generating a growing pipeline of small molecule drugs and genetic therapeuticsCompany will initially focus on oncology, fibr...
Flagship Pioneering Unveils Inzen Therapeutics Company developing new class of transformative medicines based on Thanokine Biology News provided by Share this article Share this article CAMBRIDGE, Mass., Jan. 13, 2021 /PRNewswire/ -- Flagship Pioneering, a life science platforms company, today announced the unveiling of Inzen Therapeutics. Flagship created Inzen in 2017 to discover and develop a novel class of medicines based on a previously unrecognized area of biology that exerts broad and fundamental influence on cell state, discovered and named Thanokine ™ Biology by Flagship's scienti...